我可能不会爱你

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A |     　　讯 国家统计局8月17日发布2026年7月份能源生产情况。数据显示，7月份，规模以上工业（以下简称规上工业）原煤生产同比下降，原油生产由降转增，天然气生产保持稳定，电力生产平稳有序。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。

B | 　　原煤、原油和天然气生产及相关情况　　原煤生产同比下降。7月份，规上工业原煤产量3.4亿吨，同比下降10.1%；日均产量1107万吨。　　1—7月份，规上工业原煤产量27.0亿吨，同比下降2.9%。　　原油生产由降转增。7月份，规上工业原油产量1827万吨，同比增长0.8%，6月份为下降0.5%；日均产量58.9万吨。　　1—7月份，规上工业原油产量12769万吨，同比增长0.9%。　　原油加工降幅收窄。7月份，规上工业原油加工量5311万吨，同比下降15.8%，降幅比6月份收窄1.9个百分点；日均加工量171.3万吨。　　1—7月份，规上工业原油加工量39696万吨，同比下降6.5%。　　天然气生产保持稳定。7月份，规上工业天然气产量214亿立方米，同比下降0.9%；日均产量6.9亿立方米。　　1—7月份，规上工业天然气产量1543亿立方米，同比增长1.2%。　　电力生产情况　　规上工业电力生产基本平稳。7月份，规上工业发电量9439亿千瓦时，同比略降0.1%；日均发电304.5亿千瓦时。

C | 1—7月份，规上工业发电量56985亿千瓦时，同比增长3.0%。

D | 　　分品种看，7月份，规上工业火电由增转降，水电增速加快，核电、太阳能发电增速放缓，风电由降转增。其中，规上工业火电同比下降3.5%，6月份为增长0.5%；规上工业水电增长6.7%，增速加快1.9个百分点；规上工业核电增长6.6%，增速放缓1.9个百分点；规上工业风电增长4.5%，6月份为下降5.6%；规上工业太阳能发电增长5.6%，增速放缓8.6个百分点。版权申明：凡注有“”或电头为“”的稿件，均为独家版权所有，未经许可不得转载或镜像；授权转载必须注明来源为“”，并保留“”的电头。    。

Current article:http://oaot9y.bomanglangsugangunxileba.cyou/oh7/3nd4.html

Published on:07:50:46